02

Dec

2025

18:00

CET

17:00

GMT

Webinar

DanGer Shock RCT: A Decade of Data – From Evidence to Everyday Practice

Average (ratings)
No ratings
Your rating

Overview

Gain critical insights into how the landmark DanGer Shock RCT is reshaping cardiogenic shock management, improving patient outcomes and enhancing collaborative care strategies in real-world settings.

In this webinar, leading experts and trial investigators Dr Jacob Møller (Copenhagen University Hospital, Copenhagen, DK), Dr Vasileios Panoulas (Harefield Hospital, London, UK), Prof Christian Schulze (University Hospital Jena, Jena, DE), alongside moderator Dr Andreas Goetzenich (Senior Director, Medical & Scientific Office, Johnson & Johnson MedTech Heart Recovery), discuss the trial’s decade-long impact1 on clinical decision-making and its application on a regional level.

 

The session will examine how DanGer Shock continues to shape global practice, refine treatment algorithms and guide future research in cardiogenic shock management. The programme will be of particular educational benefit for interventional cardiologists, cardiothoracic surgeons, intensivists, heart failure specialists and the multidisciplinary shock team.

 

Reference: 1. Long-Term Outcomes of the DanGer Shock Trial, N Engl J Med 2025;393:1037-1038. DOI: 10.1056/NEJMc2508284

 

Invite a Colleague to Register!

Faculty:


Andreas Goetzenich

Andreas Goetzenich


Jacob E Møller

Jacob E Møller


Vasileios Panoulas

Vasileios Panoulas


Christian Schulze

Christian Schulze

This webinar is supported by Johnson and Johnson MedTech Heart Recovery

Agenda

Welcome & Introduction

Andreas Goetzenich

Key Results Overview

Jacob E Møller

European and Global Perspectives: Country and Global Level Impact

Jacob E Møller, Christian Schulze, and Vasileios Panoulas

Future Research & Educational Needs

All

Learning Objectives

  • Review key outcomes and the value of long-term data in clinical and operational decision-making
  • Regional insights and best practices from across EMEA
  • Apply evidence-based strategies to optimise cardiogenic shock management
  • Challenges and opportunities in leveraging longitudinal data
  • Integrate multidisciplinary collaboration into clinical workflows
  • Explore future directions in cardiogenic shock care

Target Audience

  • Interventional Cardiologists
  • Cardiothoracic Surgeons
  • Heart Failure Specialists / Cardiologists
  • Non-invasive Cardiologists
  • Intensive Care Nurses
  • Anaesthetists
  • Vascular Surgeons
  • CT Technologists

Faculty Biographies


Andreas Goetzenich

Andreas Goetzenich

Dr Andreas Goetzenich is Senior Director, Medical & Scientific Office, Johnson & Johnson MedTech Heart Recovery.

View full profile

Jacob E Møller

Jacob E Møller

Prof Jacob Møller is clinical professor at the Odense University Hospital in Denmark. His main research interests include cardiogenic shock, mechanical circulatory support and invasive hemodynamic testing. 

View full profile

Vasileios Panoulas

Vasileios Panoulas

Dr Vasileios Panoulas is a consultant cardiologist based at Harefield Hospital, Harefield, UK.

He is also an honorary senior clinical lecturer at Imperial College London. 

View full profile

Christian Schulze

Christian Schulze

Professor Christian Schulze is a renowned cardiologist and researcher based in Germany, serving as Director of the Department of Internal Medicine and Cardiology at the University Hospital Jena.

View full profile